Esophagus News

CHARLOTTE, N.C. — Endoscopic therapy yielded lower rates of rebleeding, mortality and surgery compared with conservative therapy in patients with bleeding peptic ulcer diseases, according to a presenter at ACG Annual Scientific Meeting.

CHARLOTTE, N.C. — Dupilumab improved clinical, symptomatic, histologic and endoscopic outcomes among patients treated for eosinophilic esophagitis, according to study results presented at the ACG Annual Scientific Meeting.

CHARLOTTE, N.C. — Endoscopic fundoplication demonstrated comparable efficacy to its surgical counterpart in the treatment of patients with medication refractory GERD, according to a presentation at the ACG Annual Scientific Meeting.

CHARLOTTE, N.C. — Cap-assisted endoscopic removal of an esophageal food bolus or foreign body impaction yielded better technical success, en-bloc removal and faster procedure time, noted a presenter at ACG 2022 Annual Scientific Meeting.

CHARLOTTE, N.C. — Vonoprazan bested placebo for on-demand treatment of episodic heartburn in patients with nonerosive reflux disease and may offer an alternative to daily therapy, noted a presenter at the ACG Annual Scientific Meeting.

CHARLOTTE, N.C. — In a Healio video exclusive, Amrit Kamboj, MD, a gastroenterologist at Mayo Clinic Rochester, reported a predictive model accurately identified patients’ likelihood of eosinophilic esophagitis.

CHARLOTTE, N.C. — The CHESS-ALARM score was a better predictor of esophageal varices requiring treatment in patients with cirrhosis vs. other noninvasive criteria, according to data presented at the ACG Annual Scientific Meeting.

The distensibility index provides a superior metric for fibrostenotic severity vs. esophageal diameter alone in pediatric patients with eosinophilic esophagitis, according to research published in Clinical Gastroenterology and Hepatology.

Supplementation with vitamin D may alleviate allergic inflammation in the esophagus, whereas a deficiency in vitamin D may lead to a higher risk for eosinophilic esophagitis and other allergic states, according to a study published in Gut.

Researchers have identified a cell signaling pathway involved in the development of Barrett’s esophagus and esophageal adenocarcinoma, which may lead to possible life-saving therapy for this aggressive cancer.